These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6826641)

  • 1. Histological grading and clinical staging of plasmacytoma.
    Hokamp HG; Grundmann E
    J Cancer Res Clin Oncol; 1983; 105(2):197-8. PubMed ID: 6826641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone marrow histology in myeloma: its importance in diagnosis, prognosis, classification and staging.
    Bartl R; Frisch B; Burkhardt R; Fateh-Moghadam A; Mahl G; Gierster P; Sund M; Kettner G
    Br J Haematol; 1982 Jul; 51(3):361-75. PubMed ID: 7104223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of bone marrow sections, smears and immunohistological staining for immunoglobulin light chains in the diagnosis of benign and malignant plasma cell proliferations.
    Thiry A; Delvenne P; Fontaine MA; Boniver J
    Histopathology; 1993 May; 22(5):423-8. PubMed ID: 7688339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of plasma cell infiltration in bone marrow biopsies and aspirates in patients with multiple myeloma.
    Terpstra WE; Lokhorst HM; Blomjous F; Meuwissen OJ; Dekker AW
    Br J Haematol; 1992 Sep; 82(1):46-9. PubMed ID: 1419801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic relevance of a histologic classification system applied in bone marrow biopsies from patients with multiple myeloma: a histopathological evaluation of biopsies from 153 untreated patients.
    Sailer M; Vykoupil KF; Peest D; Coldewey R; Deicher H; Georgii A
    Eur J Haematol; 1995 Mar; 54(3):137-46. PubMed ID: 7720832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative study of 2 prognostic classification systems for myeloma and examination of the correlation between initial bone marrow plasmacytosis and prognosis. A propos of a homogeneous population of 50 patients followed from diagnosis to death].
    Pesce A; Cassuto JP; Grisot C; Gratecos N; Bayle J; Viot G; Dujardin P
    Nouv Rev Fr Hematol (1978); 1983; 25(5):311-7. PubMed ID: 6657481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in the diagnosis and management of myeloma.
    Greipp PR
    Semin Hematol; 1992 Jul; 29(3 Suppl 2):24-45. PubMed ID: 1509293
    [No Abstract]   [Full Text] [Related]  

  • 8. Disseminated growth of murine plasmacytoma: similarities to multiple myeloma.
    Roschke V; Hausner P; Kopantzev E; Pumphrey JG; Riminucci M; Hilbert DM; Rudikoff S
    Cancer Res; 1998 Feb; 58(3):535-41. PubMed ID: 9458102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow percentage of plasma cells in the staging of monoclonal gammopathies.
    Vercelli D; Di Guglielmo R; Guidi G; Scolari L; Buricchi L; Cozzolino F
    Nouv Rev Fr Hematol (1978); 1980; 22(2):139-45. PubMed ID: 7422542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prognostic soundness of the cytologic and histologic examination of the bone marrow in myeloma].
    Bettini R; Rapazzini P; Ferrari V; Ambruzzi AM; Mascalzi MG; Steidl L
    Recenti Prog Med; 1986; 77(7-8):357-61. PubMed ID: 3786936
    [No Abstract]   [Full Text] [Related]  

  • 11. Initial bone marrow findings in multiple myeloma. Significance of plasma cell nodules.
    Buss DH; Prichard RW; Hartz JW; Cooper MR; Feigin GA
    Arch Pathol Lab Med; 1986 Jan; 110(1):30-3. PubMed ID: 3753566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human long-term bone marrow cultures (HLTBMCs) in myelomatous disorders.
    Berneman ZN; Chen ZZ; Ramael M; Van Hoof V; Peetermans ME
    Leukemia; 1989 Feb; 3(2):151-4. PubMed ID: 2911207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myeloma escape from immunity: an "inside" job.
    Rapoport AP
    Blood; 2015 Sep; 126(12):1401-3. PubMed ID: 26384282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of bone marrow biopsy and plasma cell morphology in MM and MGUS.
    Bartl R; Frisch B
    Pathol Biol (Paris); 1999 Feb; 47(2):158-68. PubMed ID: 10192882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Appearance of monoclonal plasma cell diseases in whole-body magnetic resonance imaging and correlation with parameters of disease activity.
    Kloth JK; Hillengass J; Listl K; Kilk K; Hielscher T; Landgren O; Delorme S; Goldschmidt H; Kauczor HU; Weber MA
    Int J Cancer; 2014 Nov; 135(10):2380-6. PubMed ID: 24706394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow plasma cell infiltration in multiple myeloma.
    de Gramont A; Benitez O; Smadja N; Brissaud P; Sirinelli A; Hubert D; Krulik M; Debray J
    Br J Haematol; 1984 Jun; 57(2):351-3. PubMed ID: 6733051
    [No Abstract]   [Full Text] [Related]  

  • 17. Hepatic and renal plasma cell lesions in a patient with multiple myeloma in hematological remission.
    Galani Z; Viniou N; Kyrtsonis MC; Sachanas S; Antoniou T; Dimopoulou MN; Vassilakopoulos TP; Korkolopoulou P; Nakopoulou L; Patsouris E; Pangalis GA
    Anticancer Res; 2007; 27(1B):571-4. PubMed ID: 17348443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FDG-PET in the evaluation of myeloma in 2012.
    Bodet-Milin C; Eugène T; Bailly C; Lacombe M; Frampas E; Dupas B; Moreau P; Kraeber-Bodéré F
    Diagn Interv Imaging; 2013 Feb; 94(2):184-9. PubMed ID: 23287424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphologic heterogeneity and plasmablastic transformation in advanced plasmacytic/plasmablastic myeloma: a study of 35 serial bone marrow biopsies in 9 patients.
    Paule B; Quillard J; Bennet P; Mariette X; Bisson M
    Nouv Rev Fr Hematol (1978); 1989; 31(3):203-8. PubMed ID: 2616267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma cell dyscrasias.
    Buss DH; Prichard RW; Cooper MR
    Hematol Oncol Clin North Am; 1988 Dec; 2(4):603-15. PubMed ID: 3065321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.